Why it matters:
The Drug Tariff provides the following definitions for specials and imported products:
Specials are unlicensed medicinal products manufactured in the UK for human use which have been specially prepared to meet a prescription ordered for individual patients without the need for the manufacturer to hold a marketing authorisation for the medicinal product concerned.
Imported products are unlicensed medicinal products sourced from outside the UK under an importers licence issued by the MHRA. These products have been specially sourced to meet a prescription ordered for individual patients without the need for the importer to hold a marketing authorisation for the medicinal product concerned.
Both special and imported products have not undergone the same rigorous regulatory requirements and should, therefore, only be used when an appropriate UK-licensed product is unavailable. In addition they are frequently more expensive than licensed alternatives.
Description: Spend on specials/imported products per 1000 registered patients
Performance: Loading...
Explore:
Tagged as: (or browse all measures)
Sub-ICB Locations are ordered by mean percentile over the past six months. Each chart shows the results for the individual Sub-ICB Location, plus deciles across all Sub-ICB Locations in the NHS in England.
View measure for NHS England combined →